Altimmune (ALT) Change in Account Payables (2016 - 2025)

Altimmune (ALT) has disclosed Change in Account Payables for 16 consecutive years, with -$2.1 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 126.36% to -$2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 234.8% year-over-year, with the annual reading at $2.5 million for FY2025, 234.8% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$2.1 million at Altimmune, down from $4.0 million in the prior quarter.
  • The five-year high for Change in Account Payables was $4.0 million in Q3 2025, with the low at -$2.1 million in Q4 2025.
  • Average Change in Account Payables over 5 years is $105250.0, with a median of -$210000.0 recorded in 2021.
  • Peak annual rise in Change in Account Payables hit 872.3% in 2021, while the deepest fall reached 308.19% in 2021.
  • Over 5 years, Change in Account Payables stood at $2.0 million in 2021, then soared by 66.91% to $3.4 million in 2022, then crashed by 128.83% to -$976000.0 in 2023, then rose by 5.53% to -$922000.0 in 2024, then crashed by 126.36% to -$2.1 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$2.1 million, $4.0 million, and -$226000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.